Active Surveillance for Prostate Cancer

As part of the 2024 Prostate Cancer Patient Conference, Dr. Kevin Shee presents a comprehensive overview of active surveillance in managing localized prostate cancer. Drawing from the extensive institutional database with over 9,000 participants at UCSF, Dr. Shee highlights groundbreaking insights into the field. From exploring the safety of active surveillance in younger men to investigating the potential of prostate MRI as a biopsy alternative, you'll gain valuable insights into treatment decisions and patient outcomes. Dr. Shee's session offers a profound understanding of how data-driven approaches are shaping the future of prostate cancer management. Recorded on 03/09/2024. [5/2024] [Show ID: 39757] Recorded on 03/09/2024. [5/2024] [Show ID: 39757]

Donate to UCTV to support informative & inspiring programming:

Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.

More videos from: Prostate Cancer Patient Conference

Explore More Health & Medicine on UCTV
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.

UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.

[larryparis]

This is a highly-informative and well-organized presentation. Many thanks.

[seichewarning]

Most informative discussion I have seen. I'm low intermediate risk, 3 + 4 at age 61. I've had many different discussions with 2nd, 3rd, opinions. For now, I'm on a/s but very uncertain as to which option is best. This presentation leads me to continue on a/s although I do fear metastasis.

[dewsbury]

Excellent presentation - complex issue made understandable to the lay person!

[JB-beco]

My husband is 73 years old. He has a perfect health except a little bit frequent in urination.
Total psa shows 16.57*
After a month tested shows 10.700 ng/ml.
Free psa shows 1.900
Percentage 18%
MRI reveals pirads-3 lesion in the lower mid gland.
There are pirads-2 nodules in the transitional zone bilaterally as described.
Is here, he needs to go biopsy?

[douglascutler]

Can a patient who has received brachytherapy for single core Gleason 6 transfer to active surveillance if Gleason 6 is still the score in a new biopsy? Can't find this answer anywhere.